Shin is the Chief Commercial Officer at Hepalys Pharma, bringing over 20 years of experience in the pharmaceutical industry across Japan and global markets. His background spans commercial leadership, business strategy, and business development.

Prior to joining Hepalys, he served as Chief Commercial Officer at Renalys Pharma, where he led the overall commercial strategy for a rare renal disease portfolio. He oversaw the company’s commercial build-up and worked closely with key stakeholders in Japan and overseas, while also contributing to broader corporate and partnership strategies. He played a central role in Renalys Pharma’s strategic M&A with Chugai Pharmaceutical, leading the business evaluation and key commercial aspects of the transaction.

Earlier in his career at Takeda Pharmaceutical Company, he held senior leadership roles including Head of Established Brands, with P&L responsibility for a business exceeding JPY 100 billion. He led the marketing of more than 10 products across multiple therapeutic areas, covering all stages of the product life cycle, and became the youngest Regional Head in the company’s history, leading large sales organizations. He also gained international experience in the U.S. and Europe.

He graduated from Kwansei Gakuin University, School of Sociology.